173 related articles for article (PubMed ID: 29706844)
1. Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles.
Hu Z; Yang B; Li T; Li J
Contrast Media Mol Imaging; 2018; 2018():8710862. PubMed ID: 29706844
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer MR molecular imaging via SHP2-targeted nanoparticles.
Hu Z; Qin J; Li T; Guo J
Int J Nanomedicine; 2019; 14():7365-7373. PubMed ID: 31686812
[TBL] [Abstract][Full Text] [Related]
3. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
5. Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.
Wang Y; Sui G; Teng D; Wang Q; Qu J; Zhu L; Ran H; Wang Z; Jin C; Wang H
Biomater Sci; 2018 Dec; 7(1):196-210. PubMed ID: 30422139
[TBL] [Abstract][Full Text] [Related]
6. Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
Liu J; Xu F; Huang J; Xu J; Liu Y; Yao Y; Ao M; Li A; Hao L; Cao Y; Hu Z; Ran H; Wang Z; Li P
Biomater Sci; 2018 Nov; 6(11):2838-2849. PubMed ID: 30229771
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
8. Low-intensity focused ultrasound (LIFU)-induced acoustic droplet vaporization in phase-transition perfluoropentane nanodroplets modified by folate for ultrasound molecular imaging.
Liu J; Shang T; Wang F; Cao Y; Hao L; Ren J; Ran H; Wang Z; Li P; Du Z
Int J Nanomedicine; 2017; 12():911-923. PubMed ID: 28184161
[TBL] [Abstract][Full Text] [Related]
9. The Significance of PAX8-PPAR
Fan T; Zhu W; Kong M; Yang X; Wang C; Wang M; Wang Z
Contrast Media Mol Imaging; 2022; 2022():3265342. PubMed ID: 35833067
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor-targeted ultrasonic PFOB nanoparticles: Synthesis, characterization and application in tumor-targeted imaging.
Li K; Liu Y; Zhang S; Xu Y; Jiang J; Yin F; Hu Y; Han B; Ge S; Zhang L; Wang Y
Int J Mol Med; 2017 Jun; 39(6):1505-1515. PubMed ID: 28487935
[TBL] [Abstract][Full Text] [Related]
11. An experimental study of ovarian cancer imaging and therapy by paclitaxel-loaded phase-transformation lipid nanoparticles combined with low-intensity focused ultrasound.
Gao Y; Chen S; Li W; Wang H; Xiao K; Wu L; Li Y; Li H; Li H; Zhu Y
Biochem Biophys Res Commun; 2018 Sep; 504(1):203-210. PubMed ID: 30180951
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
[TBL] [Abstract][Full Text] [Related]
13. Bubble Inflation Using Phase-Change Perfluorocarbon Nanodroplets as a Strategy for Enhanced Ultrasound Imaging and Therapy.
Brambila CJ; Lux J; Mattrey RF; Boyd D; Borden MA; de Gracia Lux C
Langmuir; 2020 Mar; 36(11):2954-2965. PubMed ID: 32090572
[TBL] [Abstract][Full Text] [Related]
14. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
[TBL] [Abstract][Full Text] [Related]
15. Drug Release from Phase-Changeable Nanodroplets Triggered by Low-Intensity Focused Ultrasound.
Cao Y; Chen Y; Yu T; Guo Y; Liu F; Yao Y; Li P; Wang D; Wang Z; Chen Y; Ran H
Theranostics; 2018; 8(5):1327-1339. PubMed ID: 29507623
[No Abstract] [Full Text] [Related]
16. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy.
Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169
[TBL] [Abstract][Full Text] [Related]
17. Peptide-Functionalized Phase-Transformation Nanoparticles for Low Intensity Focused Ultrasound-Assisted Tumor Imaging and Therapy.
Zhu L; Zhao H; Zhou Z; Xia Y; Wang Z; Ran H; Li P; Ren J
Nano Lett; 2018 Mar; 18(3):1831-1841. PubMed ID: 29419305
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.
Johansen ML; Perera R; Abenojar E; Wang X; Vincent J; Exner AA; Brady-Kalnay SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671448
[TBL] [Abstract][Full Text] [Related]
19. Copper Sulfide Perfluorocarbon Nanodroplets as Clinically Relevant Photoacoustic/Ultrasound Imaging Agents.
Santiesteban DY; Dumani DS; Profili D; Emelianov SY
Nano Lett; 2017 Oct; 17(10):5984-5989. PubMed ID: 28926263
[TBL] [Abstract][Full Text] [Related]
20. Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodalimaging contrast agent.
Luo B; Zhang H; Liu X; Rao R; Wu Y; Liu W
Biomed Mater Eng; 2015; 26 Suppl 1():S911-6. PubMed ID: 26406092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]